Recent Developments in Salvage Chemotherapy for Patients with Metastatic Soft Tissue Sarcoma
- 1 January 2005
- journal article
- review article
- Published by Springer Science and Business Media LLC in Drugs
- Vol. 65 (2), 167-178
- https://doi.org/10.2165/00003495-200565020-00002
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- Phase II and Pharmacokinetic Study of Ecteinascidin 743 in Patients With Progressive Sarcomas of Soft Tissues Refractory to ChemotherapyJournal of Clinical Oncology, 2004
- A two‐arm phase II study of temozolomide in patients with advanced gastrointestinal stromal tumors and other soft tissue sarcomasCancer, 2003
- Doxorubicin-based chemotherapy for the palliative treatment of adult patients with locally advanced or metastatic soft tissue sarcomaEmergencias, 2003
- Phase II trial of gemcitabine in patients with advanced sarcomas (E1797)Cancer, 2003
- Vinorelbine in previously treated advanced childhood sarcomasCancer, 2002
- Phase II trial of gemcitabine in advanced sarcomasCancer, 2002
- Gemcitabine in advanced adult soft-tissue sarcomas. A phase II study of the EORTC Soft Tissue and Bone Sarcoma GroupEuropean Journal of Cancer, 2002
- New agents in the treatment of soft-tissue sarcomasExpert Opinion on Investigational Drugs, 2000
- Phase II study of raltitrexed (‘Tomudex’) for patients with advanced soft tissue sarcomas refractory to doxorubicin-containing regimensAnti-Cancer Drugs, 1999
- Temozolomide in adult patients with advanced soft tissue sarcoma: a phase II study of the EORTC Soft Tissue and Bone Sarcoma GroupEuropean Journal of Cancer, 1999